Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The properties of the Bacillus subtilis
RNase P
are characterized with regard to the types and concentrations of monovalent and divalent ions required to potentiate precursor tRNA cleavage by the protein-RNA holoenzyme and the catalytic RNA alone. The ionic dependence of the
RNase P
RNA-catalyzed reaction in part seems due to a requirement for ion shielding between substrate and catalytic RNAs. The
RNase P
protein, which binds to RNA nonspecifically and tightly, likely serves, in part, as a cation screen. However, the character of the ion dependence of the RNA catalysis, the inhibition by high
SO2
-4 concentration, and potentiation by solvents suggest that RNA conformational transition may be involved in the reaction. It is proposed that the reason for catalysis by RNA in the
RNase P
reaction may be a requirement for fluidity in the structure of the catalyst, so that it can accommodate many tRNA substrates, which vary in their structural details.
...
PMID:Ion dependence of the Bacillus subtilis RNase P reaction. 392 45